Clinical Trials

Breakthrough Antibody Therapy Offers Durable Protection Against H5N1
Research & Development Breakthrough Antibody Therapy Offers Durable Protection Against H5N1

In a significant development in avian flu research, scientists from the University of Pittsburgh and the NIH Vaccine Research Center have crafted an innovative antibody therapy aimed at tackling the severe H5N1 avian flu virus in monkeys. This new therapy focuses on a broadly neutralizing antibody,

New Study Debunks Myth Linking Sickle Cell Trait to Sudden Death
Research & Development New Study Debunks Myth Linking Sickle Cell Trait to Sudden Death

A recent study published in the American Society of Hematology's journal, Blood, has dispelled the long-held belief that sickle cell trait (SCT) can lead to sudden death, particularly under conditions of physical exertion. This misconception has disproportionately affected Black males with

TBorNotTB: New Tool Enhances TB Evaluation, Saves IPC Hours
Tech & Innovation TBorNotTB: New Tool Enhances TB Evaluation, Saves IPC Hours

The healthcare domain is witnessing a remarkable shift with the introduction of "TBorNotTB," a state-of-the-art clinical decision support system (CDSS) specifically designed for the evaluation of suspected tuberculosis (TB) cases in hospitals. The primary function of TBorNotTB is to aid

New Study Disputes Link Between Maternal Health and Autism Risk
Research & Development New Study Disputes Link Between Maternal Health and Autism Risk

A recent study conducted by researchers at NYU Langone Health has reexamined the purported link between a mother’s health during pregnancy and the likelihood of her child developing autism. This study disputes previous assertions that maternal health conditions during pregnancy contribute directly t

FDA Approves Journavx: A New Non-Opioid Solution for Acute Pain
Research & Development FDA Approves Journavx: A New Non-Opioid Solution for Acute Pain

On Thursday, the Food and Drug Administration approved Journavx, a highly anticipated non-opioid pain medication developed by Vertex Pharmaceuticals, marking a significant milestone in the effort to shift pain treatment away from opioids. This new drug has been initially approved to treat acute

Do Caregiver Support Programs Enhance Dementia Patient Outcomes?
Research & Development Do Caregiver Support Programs Enhance Dementia Patient Outcomes?

In the challenging landscape of dementia care, caregivers are the unsung heroes who shoulder the burden of looking after their loved ones. The emotional, physical, and financial stress experienced by caregivers often goes unnoticed, despite playing a crucial role in the well-being of dementia

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later